(VIANEWS) – The NASDAQ opens in less than five hours and Pacific Biosciences of California‘s pre-market value is already 9.82% up.

The last session, NASDAQ ended with Pacific Biosciences of California (PACB) falling 9.11% to $5.09. NASDAQ slid 2.47% to $12,012.73, following the last session’s downward trend on what was an all-around down trend trading session.


Today’s last reported volume for Pacific Biosciences of California is 6209702, 6.72% below its average volume of 6657373.

Pacific Biosciences of California’s last close was $5.09, 86% under its 52-week high of $36.36.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 17% for the current quarter and 30.3% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 57.1% and a negative 500%, respectively.


Pacific Biosciences of California’s last day, last week, and last month’s current intraday variation average was 10.02%, 10.51%, and 5.68%, respectively.

Pacific Biosciences of California’s highest amplitude of average volatility was 8.82% (day), 12.70% (last week), and 9.69% (last month), respectively.

More news about Pacific Biosciences of California (PACB).


Please enter your comment!
Please enter your name here